Federated Hermes
ZBIO

Federated Hermes’s Zenas BioPharma ZBIO Stock Holding History

Federated Hermes’s Portfolio ZBIO Stock Details ZBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$61.1M Buy
3,127,031
+411,453
+15% +$9.24M 0.1% 224
2025
Q4 		$98.6M Buy
2,715,578
+853,740
+46% +$28.1M 0.16% 150
2025
Q3 		$41.3M Hold
1,861,838
– – 0.07% 306
2025
Q2 		$18M Buy
1,861,838
+703,838
+61% +$6.85M 0.03% 448
2025
Q1 		$9.15M Hold
1,158,000
– – 0.02% 577
2024
Q4 		$9.48M Hold
1,158,000
– – 0.02% 556
2024
Q3 		$19.6M Buy
+1,158,000
New +$20.8M 0.04% 436

Other funds holding ZBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $176M AUM 208.78% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Federated Hermes's ZBIO Position: Q1 2026 in Review

Federated Hermes increased its Zenas BioPharma (ZBIO) stake by 15% in Q1 2026, buying an estimated $9.24M and bringing the position to 3,127,031 shares worth $61.1M. The position accounts for 0.1% of the portfolio, ranked #224.

Federated Hermes first reported a position in ZBIO in Q3 2024 and has held it in 7 quarters since. The position peaked at $98.6M in Q4 2025. 139 funds tracked by Wall St. Rank hold ZBIO as of Q1 2026.

  • Federated Hermes held 3,127,031 shares of Zenas BioPharma worth $61.1M as of Q1 2026.
  • Federated Hermes bought 411,453 Zenas BioPharma shares in Q1 2026, an estimated $9.24M.
  • Zenas BioPharma made up 0.1% of Federated Hermes's portfolio in Q1 2026, its #224 holding.
  • Federated Hermes first reported a position in Zenas BioPharma in Q3 2024 and has held it in 7 quarters since.
  • Federated Hermes's Zenas BioPharma position peaked at $98.6M in Q4 2025.
  • 139 funds tracked by Wall St. Rank held Zenas BioPharma as of Q1 2026.

Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.